Human Adipose Derived Cells in Two- and Three-Dimensional Cultures: Functional Validation of an In Vitro Fat Construct
Overview
Authors
Affiliations
Obesity, defined as a body mass index of 30 kg/m or above, has increased considerably in incidence and frequency within the United States and globally. Associated comorbidities including cardiovascular disease, type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease have led to a focus on the mechanisms promoting the prevention and treatment of obesity. Commonly utilized models employ human or mouse preadipocyte cell lines in a 2-dimensional (2D) format. Due to the structural, biochemical, and biological limitations of these models, increased attention has been placed on "organ on a chip" technologies for a 3-dimensional (3D) culture. Herein, we describe a method employing cryopreserved primary human stromal vascular fraction (SVF) cells and a human blood product-derived biological scaffold to create a 3D adipose depot in vitro. The "fat-on-chip" 3D cultures have been validated relative to 2D cultures based on proliferation, flow cytometry, adipogenic differentiation, confocal microscopy/immunofluorescence, and functional assays (adipokine secretion, glucose uptake, and lipolysis). Thus, the culture system demonstrates the critical characteristics required for a humanized 3D white adipose tissue (WAT) model.
Unilocular adipocyte and lipid tracer for immunofluorescent images.
Johnston E, Dassau T, Muraskin N, Abbott R Sci Rep. 2025; 15(1):4643.
PMID: 39920142 PMC: 11805913. DOI: 10.1038/s41598-024-80613-w.
Luca T, Pezzino S, Puleo S, Castorina S J Transl Med. 2024; 22(1):764.
PMID: 39143643 PMC: 11323604. DOI: 10.1186/s12967-024-05547-3.
Optimization and validation of a fat-on-a-chip model for non-invasive therapeutic drug discovery.
Huff L, Amurgis C, Kokai L, Abbott R Front Bioeng Biotechnol. 2024; 12():1404327.
PMID: 38988864 PMC: 11235003. DOI: 10.3389/fbioe.2024.1404327.
Mouse vascularized adipose spheroids: an organotypic model for thermogenic adipocytes.
Davidsen L, Hagberg C, Goitea V, Lundby S, Larsen S, Ebbesen M Front Endocrinol (Lausanne). 2024; 15:1396965.
PMID: 38982992 PMC: 11231189. DOI: 10.3389/fendo.2024.1396965.
Type IV Collagen Promotes Adipogenic Differentiation of Adipose Stem Cells.
Li J, Xu Y, Quan Y, He Y, Lu F, Gao J Aesthetic Plast Surg. 2024; 48(13):2536-2544.
PMID: 38538770 DOI: 10.1007/s00266-024-03890-w.